Home>Topics>Stocks>GlaxoSmithKline PLC

GlaxoSmithKline PLC GSK

  1. All
  2. Commentary
  3. Headlines
    1. ChemoCentryx says partner GSK returns rights to bowel disease drug

      Headlines

      Wed, 18 Sep 2013

      Sept 18 (Reuters) - ChemoCentryx Inc said partner GlaxoSmithKline Plc returned the rights to its inflammatory bowel disease drug, the company's lead product candidate.

    2. UPDATE 2-FDA panel supports approval of Glaxo lung drug Anoro

      Headlines

      Tue, 10 Sep 2013

      WASHINGTON, Sept 10 (Reuters) - A federal advisory panel recommended approval of GlaxoSmithKline Plc 's new drug to treat chronic obstructive pulmonary disease(COPD), but suggested the company be...

    3. FDA panel votes in favor of approval of Glaxo lung drug Anoro

      Headlines

      Tue, 10 Sep 2013

      WASHINGTON, Sept 10 (Reuters) - An federal advisory panel has recommended that the U.S. Food and Drug Administration approve a drug made by GlaxoSmithKline Plc and Theravance Inc to treat chronic...

    4. Safety data on Glaxo COPD drug inconclusive -FDA staff

      Headlines

      Fri, 6 Sep 2013

      Sept 6 (Reuters) - An experimental drug to treat chronic obstructive pulmonary disease made by GlaxoSmithKline Plc and Theravance Inc appears to work, but its safety data are not entirely conclusive,...

    5. Sarepta shares jump after disappointing test for rival drug

      Headlines

      Fri, 16 Aug 2013

      (Reuters) - Shares of Sarepta Therapeutics Inc opened 6.9 percent higher after GlaxoSmithKline Plc reported disappointing clinical data for a rival therapy to Sarepta's experimental muscle disorder...

    6. Sarepta shares jump after disappointing test for rival drug

      Headlines

      Fri, 16 Aug 2013

      Aug 16 (Reuters) - Shares of Sarepta Therapeutics Inc opened 6.9 percent higher after GlaxoSmithKline Plc reported disappointing clinical data for a rival therapy to Sarepta's experimental muscle...

    7. BRIEF-GlaxoSmithKline launches $50 mln venture capital fund

      Headlines

      Thu, 8 Aug 2013

      Aug 8 (Reuters) - GlaxoSmithKline Plc : * GSK launches $50 million venture capital fund toinvest in pioneering

    8. Optimer shares rise after report names Glaxo, Cubist as potential buyers

      Headlines

      Tue, 2 Apr 2013

      (Reuters) - Shares of Optimer Pharmaceuticals Inc rose as much as 24 percent after a Bloomberg report said GlaxoSmithKline Plc and Cubist Pharmaceuticals Inc were among those interested in buying the...

    9. An Uneasy Calm for European Markets in 1Q

      Headlines

      Sat, 30 Mar 2013

      quarter. The health-care segment was among the best-performing across Europe, with major companies such as GlaxoSmithKline PLC GSK and AstraZeneca PLC AZN gaining as much as 13% each over the quarter. Both U.K.-based companies announced

    10. UPDATE 1-FDA expands Glaxo-Ligand Promacta to hep C patients

      Headlines

      Mon, 19 Nov 2012

      Nov 19 (Reuters) - GlaxoSmithKline Plc said U.S. health regulators had approved its drug Promacta for the additional use of treating low platelet count in hepatitis C patients that will allow them to...

    « Prev12Next »
    Content Partners